CLOROX CO /DE/ (CLX): Results of Operations and Financial Condition
CLOROX CO /DE/ (CLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-pressreleasedatedaug.htm EX-99.1 Document Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, California, Aug. 3, 2026 — The Clorox Company (NYSE: CLX) today reporte
How this was made
The 30-second read
Why it matters
The filing frames FY26 results as in-line with expectations while highlighting margin pressure from acquisition inventory step-up and ERP transition lapping, alongside progress on integration and modernization. The company states FY27 starts from a stronger execution position in a challenging environment.
Market read
This is a primary earnings release via SEC 8-K with quantified quarterly performance and integration/ERP transition drivers, plus qualitative FY27 outlook.
What to watch
Gross margin decline is attributed to GOJO inventory step-up and ERP shipment comparisons; traders may over-focus on headline margin without separating one-time acquisition accounting and transition timing effects.
Background
Clorox completed the GOJO Industries acquisition in April 2026 and also completed its U.S. ERP implementation as part of a multi-year digital transformation.
Ticker impact
Clorox reported Q4 and FY26 results on an 8-K, including net sales down 2% and gross margin down 520 bps, plus FY27 outlook language.
Near-term volatility likely as traders weigh margin compression and EPS decline against the acquisition integration and FY27 execution plan.
The filing provides multiple quantified P&L drivers (sales, gross margin, EPS) and qualitative FY27 positioning, but the excerpt does not include specific FY27 numeric guidance.
Market effects
Signals ongoing cost volatility and integration-related margin headwinds for consumer staples hygiene and cleaning peers, especially those with recent acquisitions or system transitions.
Limited direct regional read-through beyond Clorox’s stated international segment FX benefit.
Moderate, as the story is company-specific but touches broader consumer value-seeking and commodity/manufacturing cost dynamics.
Counterpoint
Organic sales weakness is partly attributed to lapping ERP-related incremental shipments; excluding that effect, organic sales would have increased, which could reduce the perceived demand deterioration.
Key entities
- issuerThe Clorox Company
Reported Q4 and FY26 results and provided qualitative FY27 outlook in an SEC 8-K.
- acquisition_targetGOJO Industries, Inc.
Acquired in April 2026; its integration and inventory step-up are cited as drivers of gross margin and EPS changes.
- executiveLinda Rendle
CEO and Chair quoted on results being in line with expectations and on FY27 execution.
